Achieve Life Sciences (ACHV) Other financing activities (2010 - 2026)
Achieve Life Sciences' (ACHV) quarterly Other financing activities came in at $21000.0 in Q1 2026, down 98.34% on a QoQ basis from $1.3 million in Q4 2025.
Powered by 
Analysis
Achieve Life Sciences (ACHV) Other financing activities (2010 - 2026) Analysis & Trends
Achieve Life Sciences (ACHV) has 13 years of Other financing activities data on file, last reported at $21000.0 in Q1 2026.
- Quarterly Other financing activities changed N/A year-over-year to $21000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (changed N/A YoY) and the FY2025 annual result came in at $1.4 million, up 103.08% from the prior year.
- Other financing activities fell to $21000.0 in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $56.1 million in Q1 2024 to a low of -$55.9 million in Q3 2024.
- A 5-year average of $194916.7 and a median of $89500.0 in 2022 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2022 — Other financing activities tumbled 10100.0% — and 2024, when it jumped 72770.13%.
- Tracing ACHV's Other financing activities over 5 years: stood at -$102000.0 in 2022, then surged by 247.06% to $150000.0 in 2023, then soared by 236.0% to $504000.0 in 2024, then soared by 150.99% to $1.3 million in 2025, then tumbled by 98.34% to $21000.0 in 2026.
- The last three Other financing activities figures came in at $21000.0 (Q1 2026), $1.3 million (Q4 2025), and $120000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Achieve Life Sciences | 369.90 Mn | 369.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 139,000.00 |
| Mar 31, 2026 | 21,000.00 |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 120,000.00 |
| Dec 31, 2024 | 504,000.00 |
| Sep 30, 2024 | -55.89 Mn |
| Jun 30, 2024 | -39,000.00 |
| Mar 31, 2024 | 56.11 Mn |
| Jun 30, 2023 | 150,000.00 |
| Mar 31, 2023 | 77,000.00 |
| Sep 30, 2022 | 102,000.00 |
| Mar 31, 2022 | 24,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 95,000.00 |
| Mar 31, 2021 | 236,000.00 |
| Dec 31, 2020 | 151,000.00 |
| Sep 30, 2020 | 2.49 Mn |
| Jun 30, 2020 | -1.01 Mn |
| Mar 31, 2020 | -13,000.00 |